MARSHALL WACE, LLP - KINNATE BIOPHARMA INC ownership

KINNATE BIOPHARMA INC's ticker is KNTE and the CUSIP is 49705R105. A total of 60 filers reported holding KINNATE BIOPHARMA INC in Q3 2023. The put-call ratio across all filers is 0.76 and the average weighting 0.4%.

Quarter-by-quarter ownership
MARSHALL WACE, LLP ownership history of KINNATE BIOPHARMA INC
ValueSharesWeighting
Q3 2023$117,806
-64.1%
84,148
-22.4%
0.00%
-100.0%
Q2 2023$328,604
+260.5%
108,450
+625.7%
0.00%
Q4 2022$91,158
-33.5%
14,944
+30.5%
0.00%
Q3 2022$137,00011,4520.00%
Other shareholders
KINNATE BIOPHARMA INC shareholders Q3 2023
NameSharesValueWeighting ↓
Foresite Capital Management IV, LLC 9,671,643$225,156,00030.44%
Vida Ventures Advisors, LLC 2,747,433$63,960,00016.04%
Foresite Capital Management V, LLC 875,001$20,370,0008.01%
VR Adviser, LLC 1,473,014$34,292,0004.16%
Logos Global Management LP 1,329,602$30,953,0002.60%
RA Capital Management 3,593,052$83,646,0001.34%
Orbimed Advisors 3,847,929$89,580,0000.91%
Boxer Capital, LLC 1,065,939$24,815,0000.88%
HARVARD MANAGEMENT CO INC 498,001$11,593,0000.67%
HighVista Strategies LLC 33,391$777,0000.55%
View complete list of KINNATE BIOPHARMA INC shareholders